Search results
Trans Mountain expansion requires six more leave-to-open permits, regulator says
Reuters via Yahoo News· 2 days agoThe Canada Energy Regulator (CER) has six leave-to-open applications left to consider for the...
AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
Zacks via Yahoo Finance· 3 days agoCore earnings of $2.06 per share rose 7% year over year on a reported basis and 13% at constant...
Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up
Zacks via Yahoo Finance· 3 days agoEarnings of €1.78 per share declined 17.6% on a reported basis and 7.4% on a constant currency rate...
... €3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to...
FOX21 Colorado Springs· 6 days agoProfitability remained around 30% for the fourth consecutive year enabling the Company to pursue its expansion strategy. PARMA, Italy, April 22, 2024 /PRNewswire/ -- In 2023, Chiesi, a research-oriented ...
Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio
WKRN Nashville· 3 days ago...PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue increased 46 per cent at CER to SEK...
CONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates
Zacks· 3 days agoCONMED's (CNMD) adjusted first-quarter earnings and revenues beat estimates on the back of strong U.S. and International markets as well as supply-chain improvement.
AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance
Benzinga via Yahoo Finance· 3 days agoThursday, AstraZeneca Plc (NASDAQ:AZN) reported first-quarter sales of $12.68 billion, up 17% year...
Edwards Lifesciences (EW) Q1 Earnings Top, 2024 Sales View Up
Zacks via Yahoo Finance· 2 days agoGAAP EPS were 58 cents in the quarter, up 3.6% year over year. Sales Details First-quarter net sales...
PCORI announces $150 million in funding for new health research
Newswise· 5 days agoAmong the nine awards for patient-centered CER, two include support for large, two-phased trials...
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo Finance· 2 days agoDiabetes drug Farxiga rose 45%. AstraZeneca reiterated its financial guidance for 2024. It expects...
